Mar 4th 2024
Despite its understandable hesitancy, the pharma industry is facing a need for more widespread adoption of cloud-based solutions.
Dec 3rd 2023
The bio/pharmaceutical industry is struggling with the challenge of staffing and training.
Sep 2nd 2023
Pharma's ability to continually reinvent itself will be critical in growing future business operations.
Aug 31st 2023
Exploring the state of pharma patents following the Supreme Court’s Amgen v. Sanofi decision.
June 11th 2024
Syntegon will expand its processing and packaging by acquiring the Spanish equipment supplier.
May 31st 2024
Sterling is strengthening its development and manufacturing services for ADCs with a dedicated GMP suite at its Wisconsin facility.
May 30th 2024
Lilly’s investment increase is intended to boost manufacturing capacity at its Lebanon, Ind., site for APIs used in the production of tirzepatide and other pipeline drug candidates.
May 30th 2024
Johnson & Johnson will gain NM26, a bispecific antibody targeting atopic dermatitis, via the acquisition of a wholly owned subsidiary of Numab Therapeutics.
May 25th 2024
The partnership aims to provide end-to-end development and manufacturing for biopharmaceutical drug substance and drug product.
May 24th 2024
With the acquisition, Biogen gains felzartamab, HI-Bio's lead investigational mAb candidate being developed for the treatment of a range of immune-mediated diseases.
May 24th 2024
With this acquisition, Merck KGaA will have the capability to offer integrated services for viral vector manufacturing.
May 17th 2024
TekniPlex recently acquired Seisa Medical, which has expanded the company's services into that of a CDMO.
May 17th 2024
The new 80,000-square-foot facility will increase production of the company’s freeze-drying equipment.
May 7th 2024
ProPharm and PBL have introduced a fully automated, enclosed cell factory manufacturing device.